Two men charged with infiltrating fake Ozempic into US
Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
Lilly fleshes out triple G data in diabetes and obesity
Eli Lilly has revealed more data with its triple G agonist retatrutide, boosting its credentials as the next big thing in cardiometabolic diseases.
PhRMA hires ex-House Majority Leader Eric Cantor as its CEO
Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
uniQure falls on long-term Huntington's gene therapy data
uniQure's latest data drop for its gene therapy for Huntington's disease, under review in the US and UK, has spooked investors.
Novo turns to Hengrui for another oral obesity drug
Novo has agreed to pay up to $2.6 billion for rights to a weight-loss pill, developed by China's Hengrui Pharma, that could be dosed just once a week.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
CPHI Milan 2026 showcases new Sustainability Summit
The first-time event will bring delegates together to discuss sustainability challenges
Pharmaceutical thought leaders gather at CPHI Milan 2026
Industry leaders will address topics such as manufacturing transformation and future therapies
5th Sustainability in Life Sciences Summit
Join the global sustainability community this November in Boston
CPHI Milan Leadership Summit returns for 2026
Senior pharma leaders will tackle resilience, policy, and industry transformation at CPHI Milan
Why Join The PM Society?
The professional organisation for people working in pharmaceutical marketing and healthcare communications, and why it's worth being part of.